Apnea and its possible relationship to immunization in ex-premature infants

Peter A Cooper1, Shabir A Madhi, Robin E Huebner

  • 1Department of Paediatrics, University of the Witwatersrand, South Africa.

Vaccine
|May 21, 2008
PubMed

Insights

Infants hospitalized for apnea, particularly very low birth weight (VLBW) infants, showed more neurological issues. Some apnea cases in VLBW infants may be linked to vaccinations.

Area of Science:

  • Neonatology
  • Pediatric Neurology
  • Vaccinology

Background:

  • Apnea is a common concern in preterm infants.
  • Very low birth weight (VLBW) infants are at higher risk for complications.
  • The potential link between infant vaccinations and apnea requires investigation.

Purpose of the Study:

  • To compare the characteristics of infants hospitalized with apnea, focusing on VLBW infants.
  • To assess the incidence of neonatal neurological complications in VLBW infants with apnea.
  • To evaluate the possible association between infant immunization and the onset of apnea.

Main Methods:

  • Retrospective comparison of infants hospitalized with apnea against two control groups: infants in a vaccine trial and consecutively born VLBW infants.
  • Analysis of birth weight, gestational age, and neonatal neurological complications.
  • Assessment of apnea onset timing relative to immunization in a subset of infants.

Main Results:

  • Twenty-three infants were hospitalized with apnea, predominantly VLBW infants (<1500 g) born preterm (<37 weeks gestation).
  • VLBW infants with apnea exhibited significantly more neonatal neurological complications than VLBW controls (p=0.005).
  • Ten out of eleven infants experiencing apnea within 72 hours of immunization were potentially vaccine-related.

Conclusions:

  • VLBW infants hospitalized with apnea present with increased rates of neurological complications.
  • A potential association exists between infant vaccination and the occurrence of apnea in VLBW infants.
  • Further research is warranted to elucidate the relationship between immunizations and apnea in vulnerable infant populations.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...